1/29/25 16:35 | 1/27/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Kelderman Kim | MN | DO | CEO | S.d | -1,035 | 77.29 | 0 | -13 | -26 | 39 | D | | | | | | | | | | | | | | |
8/12/24 16:08 | 8/8/24 | TECH | Health | BioPrd | Biological Products, (No Diag | Baumgartner Robert V | MN | D | | S.d | -1,154 | 72.10 | 0 | -16 | -27 | 43 | D | | | | | | | | | | | | | | |
5/16/24 16:17 | 5/14/24 | TECH | Health | BioPrd | Biological Products, (No Diag | Higgins John L | MN | D | | S.d | -335 | 83.84 | 0 | -4 | -10 | 37 | D | | | | | | | | | | | | | | |
3/11/24 16:04 | 3/7/24 | TECH | Health | BioPrd | Biological Products, (No Diag | Nusse Roeland | MN | D | | S.d | -801 | 76.98 | 0 | -10 | -19 | 43 | D | | | | | | | | | | | | | | |
9/1/23 16:06 | 8/30/23 | TECH | Health | BioPrd | Biological Products, (No Diag | Nusse Roeland | MN | D | | S.d | -718 | 80.32 | 0 | -9 | -15 | 52 | D | | | | | | | | | | | | | | |
7/25/23 17:27 | 7/21/23 | TECH | Health | BioPrd | Biological Products, (No Diag | Kummeth Charles R. | MN | DO | CEO | S.d | -7,069 | 88.36 | 0 | -80 | -6 | 1,260 | D | | | | | | | | | | | | | | |
6/9/23 16:07 | 6/7/23 | TECH | Health | BioPrd | Biological Products, (No Diag | Kummeth Charles R. | MN | DO | CEO | S.d | -27 | 83.00 | 0 | 0 | 0 | 1,114 | D | | | | | | | | | | | | | | |
12/9/22 16:48 | 12/7/22 | TECH | Health | BioPrd | Biological Products, (No Diag | Furlow Brenda S. | MN | O | SVP - GC | S.dm | -677 | 82.11 | 0 | -8 | -18 | 37 | D | | | | | | | | | | | | | | |
8/12/22 16:02 | 8/10/22 | TECH | Health | BioPrd | Biological Products, (No Diag | Higgins John L | CA | D | | S.dm | -949 | 378.80 | 0 | -3 | -31 | 6 | D | | | | | | | | | | | | | | |
6/9/22 17:07 | 6/7/22 | TECH | Health | BioPrd | Biological Products, (No Diag | Higgins John L | MN | D | | S.dm | -584 | 364.98 | 0 | -2 | -26 | 5 | D | | | | | | | | | | | | | | |
6/9/22 17:05 | 6/7/22 | TECH | Health | BioPrd | Biological Products, (No Diag | Kummeth Charles R. | MN | DO | CEO | S.d | -1,863 | 365.00 | 0 | -5 | -3 | 199 | D | | | | | | | | | | | | | | |